HPV legislation in Michigan

Women in Government Ratings

Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :

POPULATION: 10,095,643

Incidence & Mortality (2008 Score / 2007 Score)

• Cervical Cancer Incidence Rate: 7.6/100,000 (1/ 1)
• Cervical Cancer Incidence Rate/Race: White: 6.6, Black: 11.6, Hispanic: 11.7
• Cervical Cancer Mortality Rate: 3.0/100,000 (1 / 2)
• Cervical Cancer Mortality Rate/Race: White: 1.9, Black: 4.2

Screening (2008 Score / 2007 Score)

• Cervical Cancer Screening Rate: 85.8% (2 / 2)
• Cervical Cancer Screening Rate/Race: White: 90%, Black: 89.6%, Hispanic: 86.6%
• % Uninsured/Unscreened: 22.3% (2 / 2)
• Medicaid Coverage HPV Testing: Unrestricted (2 / 2)

Healthcare Access (2008 Score / 2007 Score)

• Rate Uninsured Women: 14% (1 / 1)
• % Low Income/Uninsured Women: 29%

Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 0)

• There are no new screening requirements.

Task Forces (0 / 2)

• There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)

• HB 4104/SB 133 would require female children enrolling in the 6th grade to present proof of HPV vaccination or proof that their parent/guardian received information about HPV vaccination and declined the vaccine; referred to Committee on Health Policy.
• HB 4164/SB 132 would require the Dept. of Health to add the HPV vaccine to the list of vaccines required for school entry; referred to Committee on Health Policy.

HPV Vaccine Information Programs (1 / 1)

• HB 5171/SB 415&416 would require the Dept. of Health to provide schools with information about the risks regarding HPV and the availability of the HPV vaccine; referred to Committee on Health Policy.

Miscellaneous (1 / 1)

• SB 51 would create a specialty license plate to raise funds for breast and cervical cancer control programs; referred to Committee on Transportation.

Additional Notes

• Women In Government held a state briefing in February with state legislators, expert speakers and public health advocates.

Annual Ratings

• 2008: Good (14 out of 22 points)
• 2007: Very Good (12 out of 18 points)

Articles and resources

SourceWatch Resources

• Gardasil
• GlaxoSmithKline
• Merck
• Women in Government
• Edelman
• The Marketing of Gardasil in Australia
• The Marketing of Gardasil in Canada
• The Marketing of Gardasil in Europe
• The Marketing of Gardasil in New Zealand
• The Marketing of Gardasil in the United States
• Direct-to-consumer advertising
• Disease Mongering
• Drug industry

External links

• Judith Siers-Poisson, The Politics and PR of Cervical Cancer, a four part series, PRWatch.org, July, 2007.